Tackle social determinants of health via data and community engagement

Social determinants of health can blur the safety and efficacy profiles of therapies, making it critical for the pharmaceutical industry to find ways to ease healthcare barriers.

Patients and Medical

Engaging the economically disadvantaged

Pharma has generally done commendable work when engaging with marginalized and historically poorly-served patient populations, often...

Multichannel

Driving next best actions using timely data insights

Pharma has far more extensive data on the behavior of their healthcare providers (HCPs) and patients, which should allow them to...

Latest

Commercial
Centralize data and insights to avoid decision-making delays

Maria Aguirre G..., (Nov 24, 2023)

To help boost patient-centricity, centralization of internal and external data allows for faster insight generation among pharmaceutical company teams.
Commercial
The Engagement Use Cases for AI

Andrew Stone, (Nov 22, 2023)

A wide array of AI tools are here now or coming that will help pharma sharpen its engagement approach across medical affairs and commercial.
Access and Evidence
Tackle social determinants of health via data and community engagement

Maria Aguirre G..., (Nov 3, 2023)

Social determinants of health can blur the safety and efficacy profiles of therapies, making it critical for the pharmaceutical industry to find ways to ease healthcare barriers.
Commercial
Your 24-month blueprint for market launch success

Maria Aguirre G..., (Oct 27, 2023)

Pharmaceutical companies should have a market launch strategy at least two years before data from a registrational clinical trial is available.
Patients and Medical
Improving Pain Management and Mental Health in the Hemophilia Community: Let's Take Action

Maria Aguirre G..., (Oct 25, 2023)

Advocates at the Hemophilia Changemakers Event emphasize holistic well-being for individuals with bleeding disorders, calling for improved pain management and mental health support

Opinion

Love and sacrifice: The Zena Sfeir Story

Jill Donahue, (Mar 16, 2023)

For Zena Sfeir, Aitia VP Marketing, a strong sense of purpose is key to making an impact and improving lives

Living a resilient life: The Ana Paula Carvalho story

Jill Donahue, (Sep 5, 2022)

For Ana Paula Carvalho, President of Western Europe Cluster, Pfizer, her purpose began amidst overcoming challenges.

More Columns

Commercial

Centralize data and insights to avoid decision-making delays

Maria Aguirre G..., (Nov 24, 2023)

To help boost patient-centricity, centralization of internal and external data allows for faster insight generation among pharmaceutical company teams.
The Engagement Use Cases for AI

Andrew Stone, (Nov 22, 2023)

A wide array of AI tools are here now or coming that will help pharma sharpen its engagement approach across medical affairs and commercial.
Your 24-month blueprint for market launch success

Maria Aguirre G..., (Oct 27, 2023)

Pharmaceutical companies should have a market launch strategy at least two years before data from a registrational clinical trial is available.
Genetika+: Transforming Digital Health with Precision Medicine Innovations

Maria Aguirre G..., (Sep 6, 2023)

Pioneering the field of precision medicine, Genetika+ employs state-of-the-art technology to transform extensive datasets into actionable insights, elevating patient outcomes and providing invaluable support to pharmaceutical companies
An omnichannel strategy is necessary to meet HCP needs

Maria Aguirre G..., (Aug 25, 2023)

HCP preferences have rapidly shifted towards remote and hybrid engagement. Cultural transformation, data silo elimination, and cross-functional collaboration are key to meeting these new demands through a successful omnichannel transition.

More Commercial

Access and Evidence

Tackle social determinants of health via data and community engagement

Maria Aguirre G..., (Nov 3, 2023)

Social determinants of health can blur the safety and efficacy profiles of therapies, making it critical for the pharmaceutical industry to find ways to ease healthcare barriers.
Transform patient-driven healthcare: Synthesize RWE and AI

Maria Aguirre G..., (Sep 7, 2023)

The future of healthcare is here, and it's powered by real-world evidence (RWE) and artificial intelligence (AI), transforming patient care and clinical decision-making.
How to develop out-of-the-box evidence collection strategies to boost approval rates

Maria Aguirre G..., (Aug 18, 2023)

Enhanced evidence collection methodologies can improve approval rates and ensure reimbursement. Pharma companies should build an internal, cross-functional evidence team responsible for investigating new ways to collect and report clinical trial data
RWE’s new dataset: Social media

Andrew Stone, (Nov 22, 2022)

Pharma is waking up to the potential of social media to enhance existing RWD sources and to offer altogether new insights in rare disease and beyond
How automation is changing regulatory affairs

Andrew Stone, (Apr 14, 2022)

Post pandemic, pharma and regulators are both working to accelerate the transformative power of electronic filing

More Market Access

Patients and Medical

Achieve global scale for your digital health solutions

Maria Aguirre G..., (Nov 28, 2023)

Pharma companies are increasingly recognizing the potential of digital health solutions to transform the healthcare landscape, and many are looking to scale their digital initiatives globally.
Improving Pain Management and Mental Health in the Hemophilia Community: Let's Take Action

Maria Aguirre G..., (Oct 25, 2023)

Advocates at the Hemophilia Changemakers Event emphasize holistic well-being for individuals with bleeding disorders, calling for improved pain management and mental health support
Artificial Intelligence in Practice – How Medical Affairs Can Leverage AI Today

Maria Aguirre G..., (Oct 24, 2023)

AI is transforming Medical Affairs by analyzing data and generating insights. We gathered experts to discuss its applications in the field.
How pharma can gain public trust

Maria Aguirre G..., (Oct 13, 2023)

Pharmaceutical companies can combat misinformation and mistrust by placing the patient at the center of their overall strategies – from clinical trials to public outreach.
Engaging the economically disadvantaged

Joseph Constance, (Oct 9, 2023)

Pharma has generally done commendable work when engaging with marginalized and historically poorly-served patient populations, often focusing on ethnicity and the financially disadvantaged.

More Patients and Medical

Login

Latest

Most Popular

Opinion

Commercial

Access and Evidence

Patients and Medical

Latest Videos

Upcoming Events

December 2023

March 2024

April 2024

In-Depth Analysis